Headquartered in Lehi, UT·Fiscal year ends December·NASDAQ: WAY·waystar.com
About Waystar
Waystar Holding Corp. (Nasdaq: WAY) provides mission-critical healthcare payment software purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize financial performance. The company's enterprise-grade platform serves approximately 30,000 clients representing over 1 million distinct providers, including 16 of the 20 institutions on the U.S. News Best Hospitals list. Waystar annually processes over 7.5 billion healthcare payment transactions, including over $2.4 trillion in annual gross claims, spanning approximately 60% of U.S. patients. The platform connects providers, payers, and patients, and incorporates AI capabilities through its AltitudeAI product suite. Revenue is generated through two streams: subscription revenue and volume-based revenue, serving both provider and patient segments of the healthcare payments ecosystem. Updated
Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution. They negotiate rebates, design formularies, adjudicate claims, and steer patient adherence. Modern artificial intelligence (AI) is designed to compress each…
Alphabet reports Q4 2025 earnings today after market close. After being one of only two Magnificent Seven companies that outperformed the S&P 500 last year, Wall Street is expecting EPS of $2.64,…
Waystar Holding Corp. (Nasdaq: WAY) provides mission-critical healthcare payment software purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize financial performance.
What is the WAY stock price target?
24/7 Wall St.'s 12-month price target for WAY is $36.07, rated Buy. The Wall Street consensus target is $33.77. WAY price prediction →